WuXi Bi­o­log­ics to sell Irish vac­cine site to Mer­ck for $500M

WuXi Bi­o­log­ics’ sub­sidiary WuXi Vac­cines is di­vest­ing a man­u­fac­tur­ing fa­cil­i­ty in Dun­dalk, Ire­land, to Mer­ck for $500 mil­lion, rough­ly a week af­ter WuXi AppTec al­so …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER